Signal transduction therapy of cancer

Alexander Levitzki1, Shoshana Klein

  • 1Unit of Cellular Signaling, Department of Biological Chemistry, The Hebrew University of Jerusalem, Givat Ram, Jerusalem 91904, Israel. alex.levitzki@mail.huji.ac.il

Insights

Targeted cancer therapies aim for efficacy with minimal toxicity by exploiting cancer cells' reliance on specific signaling pathways. Developing "smart cocktails" of therapies is crucial for overcoming tumor heterogeneity and evolving resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Signal transduction therapy targets cancer-specific signaling pathways for improved efficacy and reduced toxicity.
  • Cancer cells often exhibit 'shrunken' signaling networks, leading to dependencies on fewer modules compared to healthy cells.
  • Despite promise, targeted therapies have seen limited success beyond specific cases like chronic myelogenous leukemia (CML).

Purpose of the Study:

  • To explore the principles for designing effective targeted cancer therapies.
  • To address challenges posed by tumor heterogeneity and evolving resistance.
  • To investigate optimal pathways, therapeutic molecules, and combination strategies.

Main Methods:

  • Review and synthesis of existing knowledge on cancer signaling pathways.
  • Analysis of principles for developing targeted therapeutics.
  • Consideration of rational combination strategies ('smart cocktails').

Main Results:

  • Most cancers are not dependent on a single survival factor, unlike early CML.
  • Tumor heterogeneity and evolution present significant challenges to targeted therapy.
  • The development of 'smart cocktails' is proposed as a necessary approach.

Conclusions:

  • Effective targeted cancer therapy requires a deep understanding of signaling networks and tumor biology.
  • Rational combinations of therapies are essential to overcome resistance and heterogeneity.
  • Further research is needed to identify optimal targets and combination strategies for broad clinical success.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...